 Methadone
"Methadone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3)
| Descriptor ID |
D008691
|
| MeSH Number(s) |
D02.522.675
|
| Concept/Terms |
Biodone- Biodone
- Biomet Brand of Methadone Hydrochloride
Dolophine- Dolophine
- Roxane Brand of Methadone Hydrochloride
Metadol- Metadol
- Pharmascience Brand of Methadone Hydrochloride
Metasedin- Metasedin
- Esteve Brand of Methadone Hydrochloride
Symoron- Symoron
- Yamanouchi Brand of Methadone Hydrochloride
Methadose- Methadose
- Rosemont Brand of Methadone Hydrochloride
- Mallinckrodt Brand of Methadone Hydrochloride
Methex- Methex
- Generics Brand of Methadone Hydrochloride
Physeptone- Physeptone
- Martindale Brand of Methadone Hydrochloride
- Phymet
- GlaxoSmithKline Brand of Methadone Hydrochloride
Pinadone- Pinadone
- Pinewood Brand of Methadone Hydrochloride
Methaddict- Methaddict
- addiCare Brand of Methadone Hydrochloride
|
Below are MeSH descriptors whose meaning is more general than "Methadone".
Below are MeSH descriptors whose meaning is more specific than "Methadone".
This graph shows the total number of publications written about "Methadone" by people in UAMS Profiles by year, and whether "Methadone" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2020 | 1 | 1 | 2 | | 2019 | 0 | 3 | 3 | | 2018 | 1 | 1 | 2 | | 2015 | 1 | 1 | 2 | | 2014 | 3 | 1 | 4 | | 2013 | 5 | 1 | 6 | | 2012 | 1 | 0 | 1 | | 2011 | 2 | 0 | 2 | | 2010 | 5 | 2 | 7 | | 2009 | 4 | 0 | 4 | | 2008 | 3 | 1 | 4 | | 2007 | 3 | 1 | 4 | | 2006 | 4 | 2 | 6 | | 2005 | 3 | 2 | 5 | | 2004 | 4 | 1 | 5 | | 2003 | 2 | 0 | 2 | | 2002 | 5 | 2 | 7 | | 2001 | 3 | 2 | 5 | | 2000 | 2 | 1 | 3 | | 1999 | 6 | 0 | 6 | | 1998 | 1 | 0 | 1 | | 1997 | 2 | 0 | 2 | | 1996 | 2 | 2 | 4 | | 1995 | 2 | 1 | 3 | | 1994 | 4 | 1 | 5 | | 1993 | 4 | 0 | 4 | | 1992 | 1 | 0 | 1 | | 1991 | 4 | 1 | 5 | | 1989 | 1 | 1 | 2 | | 1988 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Methadone" by people in Profiles over the past ten years.
-
Pro G, Utter J, Haberstroh S, Baldwin JA. Dual mental health diagnoses predict the receipt of medication-assisted opioid treatment: Associations moderated by state Medicaid expansion status, race/ethnicity and gender, and year. Drug Alcohol Depend. 2020 04 01; 209:107952.
-
Pro G, Zaller N. Interaction effects in the association between methadone maintenance therapy and experiences of racial discrimination in U.S. healthcare settings. PLoS One. 2020; 15(2):e0228755.
-
Meinhofer A, Hinde JM, Ali MM. Substance use disorder treatment services for pregnant and postpartum women in residential and outpatient settings. J Subst Abuse Treat. 2020 03; 110:9-17.
-
Liu J, Shah SK, Basu-Ray I, Garcia-Diaz J, Khalid K, Saeed M. QT prolongation in HIV-positive patients: Review article. Indian Heart J. 2019 Nov - Dec; 71(6):434-439.
-
Kroska EB, Meller EW, Doyle R, Coker JL, Knight BT, Ray-Griffith SL, Nembhard WN, Stowe ZN. Drug screening during pregnancy: Urine dip cups measure up. Drug Alcohol Depend. 2019 11 01; 204:107461.
-
Coker JL, Catlin D, Ray-Griffith S, Knight B, Stowe ZN. Buprenorphine medication-assisted treatment during pregnancy: An exploratory factor analysis associated with adherence. Drug Alcohol Depend. 2018 11 01; 192:146-149.
-
Brinkley-Rubinstein L, McKenzie M, Macmadu A, Larney S, Zaller N, Dauria E, Rich J. A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release. Drug Alcohol Depend. 2018 03 01; 184:57-63.
-
Timko C, Schultz NR, Cucciare MA, Vittorio L, Garrison-Diehn C. Retention in medication-assisted treatment for opiate dependence: A systematic review. J Addict Dis. 2016; 35(1):22-35.
-
Rich JD, McKenzie M, Larney S, Wong JB, Tran L, Clarke J, Noska A, Reddy M, Zaller N. Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial. Lancet. 2015 Jul 25; 386(9991):350-9.
-
Raina S, Paydak H, Al-Lahham T, Shihabuddin BS. Methadone induced Torsades de Pointes mimicking seizures in clinical presentation. Am J Drug Alcohol Abuse. 2014 Nov; 40(6):490-2.
-
Zaller N, Mazhnaya A, Larney S, Islam Z, Shost A, Prokhorova T, Rybak N, Flanigan T. Geographic variability in HIV and injection drug use in Ukraine: implications for integration and expansion of drug treatment and HIV care. Int J Drug Policy. 2015 Jan; 26(1):37-42.
-
Aklin WM, Wong CJ, Hampton J, Svikis DS, Stitzer ML, Bigelow GE, Silverman K. A therapeutic workplace for the long-term treatment of drug addiction and unemployment: eight-year outcomes of a social business intervention. J Subst Abuse Treat. 2014 Nov-Dec; 47(5):329-38.
-
Rass O, Kleykamp BA, Vandrey RG, Bigelow GE, Leoutsakos JM, Stitzer ML, Strain EC, Copersino ML, Mintzer MZ. Cognitive performance in methadone maintenance patients: effects of time relative to dosing and maintenance dose level. Exp Clin Psychopharmacol. 2014 Jun; 22(3):248-256.
-
Rajpal S, Mundi AS, Reddy PC, Akkus NI. Treatment of methadone-induced torsades de pointes with lidocaine. J La State Med Soc. 2013 Nov-Dec; 165(6):338-41.
-
Atkinson TS, Sanders N, Mancino M, Oliveto A. Effects of disulfiram on QTc interval in non-opioid-dependent and methadone-treated cocaine-dependent patients. J Addict Med. 2013 Jul-Aug; 7(4):243-8.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|